Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 170

Similar articles for PubMed (Select 9865811)

1.

Depression and stimulant dependence: neurobiology and pharmacotherapy.

Kosten TR, Markou A, Koob GF.

J Nerv Ment Dis. 1998 Dec;186(12):737-45. Review.

PMID:
9865811
2.

Neurobiological similarities in depression and drug dependence: a self-medication hypothesis.

Markou A, Kosten TR, Koob GF.

Neuropsychopharmacology. 1998 Mar;18(3):135-74. Review.

3.

Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis.

Torrens M, Fonseca F, Mateu G, Farré M.

Drug Alcohol Depend. 2005 Apr 4;78(1):1-22. Epub 2004 Nov 11. Review.

PMID:
15769553
4.

Antidepressant treatment of co-occurring depression and alcohol dependence.

Pettinati HM.

Biol Psychiatry. 2004 Nov 15;56(10):785-92. Review.

PMID:
15556124
5.

[Neurobiology and pharmacotherapy of social phobia].

Aouizerate B, Martin-Guehl C, Tignol J.

Encephale. 2004 Jul-Aug;30(4):301-13. Review. French.

PMID:
15538306
6.

Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults.

Wigal SB.

CNS Drugs. 2009;23 Suppl 1:21-31. doi: 10.2165/00023210-200923000-00004. Review.

PMID:
19621975
7.
8.

[Personality factors in depressive disorders: contribution of the psychobiologic model developed by Cloninger].

Pelissolo A, Corruble E.

Encephale. 2002 Jul-Aug;28(4):363-73. Review. French.

PMID:
12232546
9.

[Efficacy of atypical antipsychotics in depressive syndromes].

Quintin P, Thomas P.

Encephale. 2004 Nov-Dec;30(6):583-9. Review. French.

PMID:
15738862
10.

The neurobiology of antidepressants.

Blows WT.

J Neurosci Nurs. 2000 Jun;32(3):177-80. Review.

PMID:
10907206
11.

Are mood disorders and obesity related? A review for the mental health professional.

McElroy SL, Kotwal R, Malhotra S, Nelson EB, Keck PE, Nemeroff CB.

J Clin Psychiatry. 2004 May;65(5):634-51, quiz 730. Review.

PMID:
15163249
12.

[The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].

Ströhle A.

Nervenarzt. 2003 Mar;74(3):279-91; quiz 292. German.

PMID:
12627245
13.

Dopamine/serotonin releasers as medications for stimulant addictions.

Rothman RB, Blough BE, Baumann MH.

Prog Brain Res. 2008;172:385-406. doi: 10.1016/S0079-6123(08)00919-9. Review.

PMID:
18772043
14.

Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?

Zimmerman M, Mattia JI, Posternak MA.

Am J Psychiatry. 2002 Mar;159(3):469-73.

PMID:
11870014
15.

Dynamics of the dopaminergic system as a key component to the understanding of depression.

Yadid G, Friedman A.

Prog Brain Res. 2008;172:265-86. doi: 10.1016/S0079-6123(08)00913-8. Review.

PMID:
18772037
16.

Role of norepinephrine in depression.

Delgado PL, Moreno FA.

J Clin Psychiatry. 2000;61 Suppl 1:5-12. Review.

PMID:
10703757
17.

Major depression and comorbid substance use disorders.

Davis L, Uezato A, Newell JM, Frazier E.

Curr Opin Psychiatry. 2008 Jan;21(1):14-8. doi: 10.1097/YCO.0b013e3282f32408. Review.

PMID:
18281835
18.

Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence.

Grabowski J, Shearer J, Merrill J, Negus SS.

Addict Behav. 2004 Sep;29(7):1439-64. Review.

PMID:
15345275
19.

Antidepressants and the brain.

Delgado P, Moreno F.

Int Clin Psychopharmacol. 1999 May;14 Suppl 1:S9-16. Review.

PMID:
10468323
20.

The role of dopamine and norepinephrine in depression and antidepressant treatment.

Nutt DJ.

J Clin Psychiatry. 2006;67 Suppl 6:3-8. Review.

PMID:
16848670
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk